61Cu-NODAGA-LM3
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 61Cu-NODAGA-LM3, covering 2025-05-30 to 2025-05-30. Get the full timeline:
Most recent: Clinical Trial Update: 61Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET) [Phase 1, Phase 2]